<img alt="" height="1" width="1" />
Economics, not science, thwarts embryonic stem cell therapy
Los Angeles Times
Geron Corp. pulls the plug on its ambitious effort to reverse spinal damage and will focus instead on financially less risky cancer drugs. By Eryn Brown, Los Angeles Times For patients paralyzed by spinal cord injuries, Geron Corp. ...
US Senate candidate Tommy Thompson no longer champion of controversial researchPolitiFact
Geron&#39;s exit symbolic ding for stem cell researchHouston Chronicle
PolitiFact: Did Thompson flip on stem cell stance?Milwaukee Journal Sentinel
Monterey County Herald -SmallCap Network -IBNLive.com
all 14 news articles &raquo;